Decreased appetite was the most frequently reported AE in the FAERS database, including exenatide (n = 6,125, 58.61%), dulaglutide (n = 2,331, 48.09%), liraglutide (n = 1,174, 41.05%), semaglutide (n = 1,377, 47.40%), and tirzepatide (n = 550, 50.51%), with the exception that it is also one of the therapeutic effects of GLP-1 RAs, therefore, decreased appetite was analyzed only at the HLT level (Supplementary Table S2)
Learn more about how we can address your aesthetic concerns and renew your confidence
Also, not every generic may launch immediately in every format
After exposure to an irritant, the irritant will exert toxic effects on keratinocytes